Table 6.
Contingency tables of estrogen receptor protein (binned at three levels: 0, 5–50, 60–100) versus the ER-induced and RANK pathways in the breast cancer data set of van't Veer et al. [15]. Same notation as in Table 5.
| ERp low | ERp med. | ERp high | |
| ER-ind pw(+) | 0 | 5 | 25 |
| ER-ind pw(-) | 31 | 3 | 3 |
| ER-ind pw(U) | 8 | 16 | 26 |
| p-value: 2e-14 | |||
| ERp low | ERp med. | ERp high | |
| RANK pw(+) | 25 | 2 | 2 |
| RANK pw(-) | 1 | 5 | 24 |
| RANK pw(U) | 13 | 17 | 28 |
| p-value: 1e-11 | |||